Previous 10 | Next 10 |
Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States PR Newswire UDX also announces the initial closing of its series B financing of approximately $70 mil...
NORTHAMPTON, MA / ACCESSWIRE / November 15, 2023 / Quest Diagnostics Originally published in Quest Diagnostics Corporate Responsibility Report 2022 Our global suppliers play a significant role in enabling us to deliver safe and high-quality services to patients. We expect our suppliers to u...
NORTHAMPTON, MA / ACCESSWIRE / November 13, 2023 / Quest Diagnostics Quest has been getting a lot of recognition lately and is showing up on a number of influential lists. The recognition began earlier this year with our ninth straight appearance on FORTUNE Magazine's 2023 "World's Most Admire...
NORTHAMPTON, MA / ACCESSWIRE / November 9, 2023 / Quest Diagnostics Originally published in Quest Diagnostics Corporate Responsibility Report 2022 At Quest, we believe that strong corporate governance is essential for our success. Oversight of corporate responsibility and our ESG priorities ...
Quest Diagnostics Launches Mobile Phlebotomy Service, Enabling Convenient At-Home Specimen Collection in the United States PR Newswire Quest Mobile™ has 5,000 trained mobile phlebotomists whose reach will extend to 44 states by the end of 2023 SECAUCUS, N.J. ...
NORTHAMPTON, MA / ACCESSWIRE / November 8, 2023 / Quest Diagnostics Quest Diagnostics was recently recognized by the Executive Women of New Jersey (EWNJ) at the A Seat at the Table Corporate Gender Diversity Awards Breakfast. Quest, a Gold Sponsor of the event, was honored for making the EWN...
NORTHAMPTON, MA / ACCESSWIRE / November 6, 2023 / Quest Diagnostics: Summer Intern Spotlight: Key learnings from Quest for Health Equity interns Over the summer, the Quest for Health Equity (Q4HE) team spearheaded a summer internship program, working with business leaders across the Quest Di...
NORTHAMPTON, MA / ACCESSWIRE / November 1, 2023 / Quest Diagnostics Originally published in Quest Diagnostics Corporate Responsibility Report 2022 2022 highlights Quest employees completed over 1 million hours of training, an average of over 24 hours per full-time employee Nearly 1,000 ...
2023-10-30 17:02:12 ET More on Quest Diagnostics Quest Diagnostics: Moving Past Covid Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues Quest Diagnostics Non-GAAP EPS of $2.22 beats by $0.03, revenue of $2.3B beats...
Quest Diagnostics Prices $750 Million of Senior Notes PR Newswire SECAUCUS, N.J. , Oct. 30, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public o...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-24 07:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $154.00 for DGX on 2024-07-24 06:36:00. The adjusted price target was set to $154.00. At the time of the announcement, DGX was trading at $140.96. The overall price target consensus is at ...